0001209191-19-006630.txt : 20190201 0001209191-19-006630.hdr.sgml : 20190201 20190201202527 ACCESSION NUMBER: 0001209191-19-006630 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190201 FILED AS OF DATE: 20190201 DATE AS OF CHANGE: 20190201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Howton David T CENTRAL INDEX KEY: 0001529297 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 19561414 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-01 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001529297 Howton David T 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 SVP, General Counsel Common Stock 2019-02-01 4 M 0 3125 13.71 A 31196 D Common Stock 2019-02-01 4 M 0 1548 13.71 A 32744 D Common Stock 2019-02-01 4 M 0 16827 23.85 A 49571 D Common Stock 2019-02-01 4 S 0 30000 140.00 D 19571 D Stock Option (right to buy) 13.71 2019-02-01 4 M 0 3125 13.71 D 2017-02-28 2026-02-28 Common Stock 3125 6965 D Stock Option (right to buy) 13.71 2019-02-01 4 M 0 1548 13.71 D 2016-09-19 2025-09-19 Common Stock 1548 5883 D Stock Option (right to buy) 23.85 2019-02-01 4 M 0 16827 23.85 D 2013-11-05 2022-11-05 Common Stock 16827 116405 D This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. /s/ David Tyronne Howton 2019-02-01